National Cancer Institute active clinical trial for non-small cell lung cancer
Trial name: Crizotinib in Treating Patients with Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 1265 locations
Crizotinib is a cancer medication that interferes with the growth and spread of cancer cells in the body. Xalkori is used to treat non-small cell lung cancer. Crizotinib may also be used for purposes not listed in this medication guide.
Please find details on www.cancer.gov .
